Fenoverine-d8

CAT: 0804-HY-107349S-01Size: 100 µgDry Ice: NoHazardous: No
CAT#:0804-HY-107349S-01Size:100 µg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Fenoverine-d8 is the deuterium labeled Fenoverine. Fenoverine (Spasmopriv) is an orally active and powerful anti-spasmodic drug. Fenoverine reduces calcium ion influx by suppressing voltage dependent calcium channels. Fenoverine has antiemetic, analgesic, and antidiarrheal effects. Fenoverine induces rhabdomyolysis. Fenoverine can be used to study smooth muscle overexcitation related conditions such as gastrointestinal spasms[1][2][3].
Product Name Alternative
Spasmopriv-d8
UNSPSC
12352005
Target
Calcium Channel; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Purity
98.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1C2=C(C=CC=C2)SC3=CC=CC=C13)CN4C([2H])([2H])C([2H])([2H])N(CC5=CC=C(OCO6)C6=C5)C([2H])([2H])C4([2H])[2H]
Molecular Formula
C26H17D8N3O3S
Molecular Weight
467.61
References & Citations
[1]J Mironneau, et al. Fenoverine inhibition of calcium channel currents in single smooth muscle cells from rat portal vein and myometrium. Br J Pharmacol. 1991 Sep;104 (1) :65-70. |[2]Chung-Wen Chen, et al. Rhabdomyolysis induced by fenoverine: a case report and literature review. Acta Neurol Taiwan. 2005 Sep14 (3) :143-6.|[3]Hu OY, et al. Determination of fenoverine, a modulator of smooth muscle motility, in capsules and in human plasma: application to dosage form stability and a pilot study in humans. J Pharm Sci. 1992 Jan;81 (1) :91-3.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported